abstract |
This present invention provides gemcabene pharmaceutically acceptable salts having a PSD90 of 35 µm to about 90 µm, methods for purifying crude gemcabene, pharmaceutically acceptable salts of purified gemcabene, pharmaceutical compositions of a gemcabene pharmaceutically acceptable salt and therapeutic and prophylactic methods useful for various conditions, including dyslipidemia. |